117 related articles for article (PubMed ID: 25035963)
1. Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity.
Mitrakas AG; Kalamida D; Koukourakis MI
Anticancer Drugs; 2014 Nov; 25(10):1182-91. PubMed ID: 25035963
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.
Biernacka KM; Persad RA; Bahl A; Gillatt D; Holly JM; Perks CM
Endocr Relat Cancer; 2017 Jan; 24(1):17-30. PubMed ID: 27754854
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
[TBL] [Abstract][Full Text] [Related]
4. Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro.
Uehara T; Mitsuhashi A; Tsuruoka N; Shozu M
Oncol Rep; 2015 Feb; 33(2):744-50. PubMed ID: 25421433
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
[TBL] [Abstract][Full Text] [Related]
6. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
7. Metformin and caffeic acid regulate metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell cycle regulation.
Tyszka-Czochara M; Bukowska-Strakova K; Majka M
Food Chem Toxicol; 2017 Aug; 106(Pt A):260-272. PubMed ID: 28576465
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer Line.
Gallyas F; Ramadan FHJ; Andreidesz K; Hocsak E; Szabo A; Tapodi A; Kiss GN; Fekete K; Bognar R; Szanto A; Bognar Z
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163464
[TBL] [Abstract][Full Text] [Related]
9. Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Cordes N; Beinke C; Plasswilm L; van Beuningen D
Strahlenther Onkol; 2004 Mar; 180(3):157-64. PubMed ID: 14991204
[TBL] [Abstract][Full Text] [Related]
10. Metformin and prostate cancer stem cells: a novel therapeutic target.
Mayer MJ; Klotz LH; Venkateswaran V
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
[TBL] [Abstract][Full Text] [Related]
11. Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition.
Richard SM; Martinez Marignac VL
J Cancer Res Ther; 2015; 11(2):336-40. PubMed ID: 26148596
[TBL] [Abstract][Full Text] [Related]
12. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutathione S-transferase M1 by new gabosine analogues is essential for overcoming cisplatin resistance in lung cancer cells.
Wang CH; Wu HT; Cheng HM; Yen TJ; Lu IH; Chang HC; Jao SC; Shing TK; Li WS
J Med Chem; 2011 Dec; 54(24):8574-81. PubMed ID: 22085405
[TBL] [Abstract][Full Text] [Related]
14. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
[TBL] [Abstract][Full Text] [Related]
15. Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.
Li L; Han R; Xiao H; Lin C; Wang Y; Liu H; Li K; Chen H; Sun F; Yang Z; Jiang J; He Y
Clin Cancer Res; 2014 May; 20(10):2714-26. PubMed ID: 24644001
[TBL] [Abstract][Full Text] [Related]
16. Acquired drug resistance interferes with the susceptibility of prostate cancer cells to metabolic stress.
Catapano J; Luty M; Wróbel T; Pudełek M; Piwowarczyk K; Kędracka-Krok S; Siedlar M; Madeja Z; Czyż J
Cell Mol Biol Lett; 2022 Nov; 27(1):100. PubMed ID: 36401206
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative action of metformin in human lung cancer cell lines.
Ashinuma H; Takiguchi Y; Kitazono S; Kitazono-Saitoh M; Kitamura A; Chiba T; Tada Y; Kurosu K; Sakaida E; Sekine I; Tanabe N; Iwama A; Yokosuka O; Tatsumi K
Oncol Rep; 2012 Jul; 28(1):8-14. PubMed ID: 22576795
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
Chen G; Nicula D; Renko K; Derwahl M
Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
[TBL] [Abstract][Full Text] [Related]
19. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
Ma G; Cai H; Gao L; Wang M; Wang H
World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
